Bioreactor expansion of human mesenchymal stem cells according to GMP requirements

Methods in Molecular Biology

Volumn 1283, Issue , 2015, Pages 199-218

  Elseberg, Christiane L ^a   Salzig, Denise ^a   Czermak, Peter ^a  

^a NONE

Author keywords

Authorities; GMP protocol; hMSC; PAT; SOP

Indexed keywords

ADIPOGENESIS; ARTICLE; BIOREACTOR; CALIBRATION; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; INSTRUMENT STERILIZATION; MESENCHYMAL STEM CELL; PH; PRIORITY JOURNAL; PROCESS MONITORING; QUALITY CONTROL; STEM CELL EXPANSION; STIRRED REACTOR; THAWING; BATCH CELL CULTURE; CYTOLOGY; DEVICES; MESENCHYMAL STROMA CELL; METABOLISM; PRACTICE GUIDELINE; PROCEDURES; STANDARDS;

BATCH CELL CULTURE TECHNIQUES; BIOREACTORS; GUIDELINE ADHERENCE; HUMANS; MESENCHYMAL STROMAL CELLS; QUALITY CONTROL;

EID: 84923043281     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_117     Document Type: Article

References (25)

1. Hambor JE (2012) Bioreactor design and bio-process controls for industrialited cell processing. BioProcess Int 10(6):22–33
2. Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709–717
3. Salzig D, Ehlicke F, Dorresteijn A, Czermak P (2011) Potential of mesenchymal stem cells for regeneration of intervertebral disc. Biomateria-lien 12(1–4):198
4. Oppermann T, Leber J, Elseberg C, Salzig D, Czermak P (2014) hMSC production in disposable bioreactors in compliance with cGMP guidelines and PAT. Am Pharmaceut Rev Bioprocess 4
5. Jung S, Panchalingam KM, Wuerth RD, Rosenberg L, Nehie LA (2012) Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Bio-chem 59(2):106–120
6. Chen AK, Reuveny S, Oh SK (2013) Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Bio-technol Adv 31(7):1032–1046
7. Reicin C, McMahon E, Chung C (2012) Stem cell therapy regulation in Canada: implications of the prochymal approval. Westlaw J 28:1–4
8. Wang S, Qu X, Zhao R (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:1–9
9. English K, French A, Wood K (2010) Mesen-chymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7:431–442
10. Lindgren CG (2009) Standard operating procedures. In: Gee A (ed) Cell therapy: cGMP facilities and manufacturing. Springer, New York, NY
11. Unger C, Skottman H, Blomberg P, Dilber M, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17(1):48–53
12. Salzig D, Schmiermund A, Pino-Grace P, Else-berg C, Weber C, Czermak P (2013) Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a biore-actor. Open Biomed Eng J 7:147–158
13. Cierpka K, Elseberg C, Niss K, Kassem M, Salzig D, Czermak P (2013) hMSC production in disposable bioreactors with regards to GMP and PAT. Chem Ing Tech 85(1–2):67–75
14. Weber C, Pohl S, Freimark D, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P (2010) Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier: part A— inoculation, cultivation, and cell harvest procedures. Int J Artif Org 33(8):512–525
15. Weber C, Pohl S, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P (2010) Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier: part B—modeling and scale up. Int J Artif Org 33(11):782–795
16. Weber C, Pohl S, Poertner R, Pino-Grace P, Freimark D, Wallrapp C, Geigle P, Czermak P (2010) Production process for stem cell based therapeutic implants: expansion of the production cell line and cultivation of encapsulated cells. Adv Biochem Eng Biotechnol 123:143–162
17. Weber C, Pohl S, Poertner R, Wallrapp C, Geigle P, Czermak P (2009) Fixed bed reactor systems for the expansion and differentiation of stem cells for cell therapy. Int J Artif Organs 32 (7):418
18. Czermak P, Weber C, Pohl S, Poertner R, Wall-rapp C, Geigle P (2008) Development of a production process for stem cell based cell therapeutic implants. Int J Artif Organs 31(7):584
19. Czermak P, Weber C, Salzig D, Pörtner R, Wallrapp C, Hudel K (2011) Stammzellba-sierte zelltherapeutische Implantate: Entwick-lung eines Herstellungs- und Kryokonservierungsverfahrens. Biomaterialien 12(1–4):187
20. Freimark D, Sehl C, Grein T, Weber C, Hudel K, Glasmacher B, Czermak P (2010) Stem cell based therapeutic implants: production and storage. Int J Artif Organs 33(7):426
21. Justice C, Leber J, Salzig D, Wallrapp C, Kassem M, Kraume M, Czermak P (2012) Microcarrier based expansion process of hMSCs in highly vital and non-differentiated quality. Int J Artif Organs 35(2):39–107
22. Druzinec D, Weiss K, Elseberg C, Salzig D, Kraume M, Poertner R, Czermak P (2014) Process analytical technology (PAT) in insect and mammalian cell culture processes: dielectric spectroscopy and focused beam reflectance measurement (FBRM). Methods Mol Biol 1104:313–341
23. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesen-chymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
24. Justice C, Leber J, Freimark D, Pino-Grace P, Kraume M, Czermak P (2011) Online- and offline-monitoring of stem cell expansion on microcarrier. Cytotechnol 63(4):325–335. doi:10.1007/s10616-011-9359-4
25. Justice C, Brix A, Freimark D, Kraume M, Pfromm P, Eichenmueller B, Czermak P (2011) Process control in cell culture technology using dielectric spectroscopy. Biotechnol Adv 29(4):391–401